No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
MatsukiyoCocokara & Co., a Japanese enterprise, manages an extensive chain of pharmacies and drugstores throughout the nation. By June 30, 2020, its operations included 1,726 establishments distributed across all 47 prefectures of Japan. The company was founded in 1932 and maintains its headquarters in Matsudo, Japan.
www.matsukiyococokara.comNo one on the platform currently holds 3088.T.
No tracked institution reports a position in 3088.T as of their last filing.
No one on the platform has traded 3088.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 12.7% | 10.9% | 11.6% | — | — | — |
| Rev. Growth % | 5.3% | 15.5% | ||||
| Profit Margin % | 5.0% | 4.8% | 4.5% | |||
| Free Cash Flow Margin % | 5.4% | 5.3% | 4.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $1.17T | +4.9% | $153.33 | $149.95–$159.77 | — | 9 |
| 2028 | $1.21T | +3.2% | $163.16 | $150.53–$177.95 | — | 10 |
| 2029 | $1.25T | +3.2% | $171.73 | $153.18–$189.10 | — | 8 |
| 2030 | $1.29T | +3.0% | $199.60 | $196.12–$203.27 | — | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-10 | $35.35 | $37.59 | +6.3% |
| 2026-05-13 | $35.99 | $33.19 | -7.8% |
| 2026-02-13 | $42.35 | $40.37 | -4.7% |
| 2025-11-13 | $34.28 | $35.66 | +4.0% |
| 2025-08-13 | $35.26 | $32.30 | -8.4% |
| 2025-05-09 | $27.25 | $32.40 | +18.9% |
| 2025-02-14 | $39.56 | $40.13 | +1.4% |
| 2024-11-14 | $31.83 |
| $32.38 |
| +1.7% |
| +1.55% |
| $1.17T |
| — |
| 4523.TEisai Co., Ltd. | $4743.00 | +1.82% | $1.34T | — |
| 4528.TOno Pharmaceutical Co., Ltd. | $2337.50 | +0.75% | $1.10T | — |
Source: Financial Modeling Prep · peers by sector/industry